Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma through the VEGFR2/ERK/STAT3 Signaling Pathway

Transformed follicular lymphoma (t-FL), for which there is no efficient treatment strategy, has a rapid progression, treatment resistance, and poor prognosis, which are the main reasons for FL treatment failure. In this study, we identified a promising therapeutic approach with chiauranib, a novel o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yuanfang, Zhong, Mengya, Pan, Guangchao, Tan, Jinshui, Xie, Chendi, Jiang, Yuelong, Yao, Jingwei, Shan, Weihang, Lin, Jiaqi, Huang, Jiewen, Liu, Yating, Li, Zhifeng, Xu, Bing, Zha, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865968/
https://www.ncbi.nlm.nih.gov/pubmed/36678513
http://dx.doi.org/10.3390/ph16010015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865968/
https://www.ncbi.nlm.nih.gov/pubmed/36678513
http://dx.doi.org/10.3390/ph16010015

Ejemplares similares